The Cytel Blog: Perspectives on Enquiry & Evidence

A recent publication in Biometrics ‘A Gatekeeping Procedure to Test a Primary and a Secondary Endpoint in a Group..

 The Global Cardiovascular Clinical Trialists Forum is a key event bringing together leading experts from across the..

Following the recent publication of their review article Adaptive Designs for Clinical Trials in the New England..

 'The aim of a discussion should not be victory but progress.' This principle, expressed by the French essayist Joseph..

One consideration every sponsor of a biomarker-stratified confirmatory trial must take into account, is whether to..

Most people familiar with adaptive clinical trial designs are familiar with those statistical designs that reject the..

Powering a trial for superiority can be financially risky. In some instances it may also prove unnecessary.

Cytel President and co-founder Cyrus Mehta has co-authored a paper on Infantile Hemangioma, recently published in the..

Cardiovascular outcome trials (CVOTs) have earned the reputation of being the untamable behemoths of the clinical..